Saulnier et al., 2009 - Google Patents
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foodsSaulnier et al., 2009
View HTML- Document ID
- 631230889353314412
- Author
- Saulnier D
- Spinler J
- Gibson G
- Versalovic J
- Publication year
- Publication venue
- Current opinion in biotechnology
External Links
Snippet
The technologies of metagenomics and metabolomics are broadening our knowledge of the roles the human gut microbiota play in health and disease. For many years now, probiotics and prebiotics have been included in foods for their health benefits; however, we have only …
- 235000013376 functional food 0 title abstract description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5116—Other non-digestible fibres
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saulnier et al. | Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods | |
Ceapa et al. | Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health | |
Quigley | The enteric microbiota in the pathogenesis and management of constipation | |
Kondepudi et al. | Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile | |
Hernández-Hernández et al. | Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus | |
De Vries et al. | Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract | |
Jankovic et al. | Application of probiotics in food products—challenges and new approaches | |
Foligné et al. | Probiotics from research to market: the possibilities, risks and challenges | |
Harzallah et al. | Lactic acid bacteria as probiotics: characteristics, selection criteria and role in immunomodulation of human GI muccosal barrier | |
Pompei et al. | In vitro comparison of the prebiotic effects of two inulin-type fructans | |
Grimoud et al. | In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics | |
Macfarlane | Prebiotics in the gastrointestinal tract | |
Foligné et al. | Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni | |
US9579353B2 (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
CN102548566B (en) | Lactobacillus plantarum strains as hypocholesterolemic agents | |
Gomez Quintero et al. | The future of synbiotics: rational formulation and design | |
JP6974483B2 (en) | New bifidobacteria probiotic strain | |
DK2459203T3 (en) | Lactic Acid Bacteria and Bifidobacteria for the Treatment of Endotoxemia | |
Walker et al. | Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition | |
US20200121740A1 (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
Khalil et al. | Probiotic characteristics of exopolysaccharides-producing lactobacillus isolated from some traditional Malaysian fermented foods | |
Kumari et al. | Probiotics, prebiotics, and synbiotics: Current status and future uses for human health | |
Zanoni et al. | Growth kinetics on oligo‐and polysaccharides and promising features of three antioxidative potential probiotic strains | |
Nataraj et al. | Evolutionary concepts in the functional biotics arena: a mini-review | |
Shafi et al. | Prevention and control of diseases by use of pro-and prebiotics (synbiotics) |